Business Model - ALBAN PHARMA
Position:Home > About us > Business Model

ALBAN has established a unique platform or networks to render CDMO/CMO services. The platform/networks consist of multiple qualified contract pharmaceutical manufacturing sites with US FDA cGMP, EU GMP and/or CFDA GMP approval for OSDs (tablets and capsules) with annual production capacity of up to 5 billion tablets and for Injectable dedicated for high sensitivity pharmaceuticals and small molecule anticancer drugs and with annual production capacity of up to 30 million vials. Through professional and dedicated project management of ALBAN team, we can meet the demands of all kinds of CDMO/CMO customers for product development and commercial manufacturing.


Based on ALBAN’s rich and strong strengths in FDA/EU/JAPAN/CFDA- GMP and Drugs registration experts and CDMO/CMO project management expertise, we can provide one-stop contract manufacturing management service for clients come from Europe, US, Japan and China via taking PM (project management) system.